{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:10:36Z","timestamp":1791616236362,"version":"4.3.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Mucosal innate lymphoid cells (ILCs) act as cytokine producers in first line defense but also as contributors to chronic inflammation. We have previously shown that ILCs belong to those non-conventional lymphocytes promoting an IL-17A-rich tissue environment in endstage lung tissue. Here, we provide an in-depth characterization of ILCs in lung and lung-draining lymph nodes (LNs) from patients with three endstage lung diseases, i.e. cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD)\/emphysema, and pulmonary fibrosis, which reveals critical differences to healthy lung tissue. Our analyses show that type 3 ILCs dominate the ILC compartment in lungs and LNs from these three endstage lung disease entities, where they contribute to the pro-inflammatory cytokine milieu in the tissue, whereas type 1 ILCs constitute the major ILC population in healthy lung tissue. In contrast to the endstage situation, in the peripheral blood (PB) of clinically stable CF patients, we find type 2 ILCs at increased frequencies compared to healthy controls. In CF patients receiving the CFTR modulator elexacaftor\/tezacaftor\/ivacaftor (ETI), these differences in PB ILC composition are sustained for up to 24 months, in spite of significant reductions of systemic inflammation, which accompany strong improvements in lung function. These findings suggest that the local and systemic ILCs compartments reflect unique immunological aspects of chronic lung disease which appear challenging to address by disease-modifying treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1716115","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:50:21Z","timestamp":1781106621000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Type 3 innate lymphoid cells dominate the ILC compartment in endstage lung disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Olga","family":"Halle","sequence":"first","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]},{"name":"German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Niklas","family":"Falke","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]},{"name":"German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kessemeier","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]},{"name":"German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khatuna","family":"Lobjanidze","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Fuchshuber","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Br\u00fcske","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Gaedcke","sequence":"additional","affiliation":[{"name":"German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)","place":["Hannover, Germany"]},{"name":"Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Londa","family":"D\u00e4hne","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Knaup","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maresa","family":"Borghorst","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Pallenberg","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Albrecht","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adan Chari","family":"Jirmo","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]},{"name":"German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Bergmann","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Paulsen","sequence":"additional","affiliation":[{"name":"Department of Translational Pulmonology, University of Heidelberg, Heidelberg, Germany, and Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL)","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Jonigk","sequence":"additional","affiliation":[{"name":"German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)","place":["Hannover, Germany"]},{"name":"Institute of Pathology, University Medical Center, RWTH University Aachen","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Braubach","sequence":"additional","affiliation":[{"name":"German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)","place":["Hannover, Germany"]},{"name":"Department for Pathology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Dittrich","sequence":"additional","affiliation":[{"name":"Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School","place":["Hannover, Germany"]},{"name":"German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)","place":["Hannover, Germany"]},{"name":"Cluster of Excellence RESIST (EXC 2155), German Research Foundation (DFG), Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells--a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1172\/jci124617","article-title":"The balance of power: innate lymphoid cells in tissue inflammation and repair","volume":"129","author":"Castellanos","year":"2019","journal-title":"J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1900716","DOI":"10.1183\/13993003.00716-2019","article-title":"IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease","volume":"57","author":"Hagner","year":"2021","journal-title":"Eur Respir J"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1398","article-title":"Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases","volume":"11","author":"Albrecht","year":"2022","journal-title":"Clin Transl Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01597","article-title":"The influence of innate lymphoid cells and unconventional T cells in chronic inflammatory lung disease","volume":"10","author":"Borger","year":"2019","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100424","article-title":"Mucosal immunity in cystic fibrosis","volume":"207","author":"Bojanowski","year":"2021","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2500150","DOI":"10.1183\/13993003.00150-2025","article-title":"Reduction of systemic inflammation by elexacaftor\/tezacaftor\/ivacaftor correlates with lung function improvement in cystic fibrosis","volume":"66","author":"Halle","year":"2025","journal-title":"Eur Respir J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s1569-1993(22)00874-8","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on lung clearance index and magnetic resonance imaging in patients with cystic fibrosis and one or two F508del alleles","volume":"206","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202110-2249oc","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on CFTR function in patients with cystic fibrosis and one or two F508del alleles","volume":"205","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2202153","DOI":"10.1183\/13993003.02153-2022","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis","volume":"62","author":"Schaupp","year":"2023","journal-title":"Eur Respir J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01454-22","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor therapy on the cystic fibrosis airway microbial metagenome","volume":"10","author":"Pallenberg","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2400004","DOI":"10.1016\/s1569-1993(22)00874-8","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles","volume":"64","author":"Stahl","year":"2024","journal-title":"Eur Respir J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.20668","article-title":"A versatile platform for comprehensive chip-based explorative cytometry","volume":"75","author":"Hennig","year":"2009","journal-title":"Cytometry A"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.06.047","article-title":"High-content cytometry and transcriptomic biomarker profiling of human B-cell activation","volume":"133","author":"Hennig","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1002\/eji.202170126","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)","volume":"51","author":"Cossarizza","year":"2021","journal-title":"Eur J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41590-019-0423-0","article-title":"c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies","volume":"20","author":"Bernink","year":"2019","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1002\/eji.201848006","article-title":"Expression of c-Kit discriminates between two functionally distinct subsets of human type 2 innate lymphoid cells","volume":"49","author":"Hochdorfer","year":"2019","journal-title":"Eur J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00072","article-title":"Functional differences between human NKp44(-) and NKp44(+) RORC(+) innate lymphoid cells","volume":"3","author":"Hoorweg","year":"2012","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2201402","DOI":"10.1183\/13993003.01402-2022","article-title":"Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor-tezacaftor-ivacaftor, Germany, 2012-2021","volume":"61","author":"Ringshausen","year":"2023","journal-title":"Eur Respir J"},{"key":"B21","doi-asserted-by":"crossref","first-page":"1158207","DOI":"10.3389\/fphar.2023.1158207","article-title":"Post-approval studies with the CFTR modulators elexacaftor-tezacaftor-ivacaftor","volume":"14","author":"Tummler","year":"2023","journal-title":"Front Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1287","article-title":"Quantification and role of innate lymphoid cell subsets in chronic obstructive pulmonary disease","volume":"10","author":"Blomme","year":"2021","journal-title":"Clin Transl Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145961","article-title":"Characterization and quantification of innate lymphoid cell subsets in human lung","volume":"11","author":"De Grove","year":"2016","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3443","article-title":"Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs","volume":"17","author":"Silver","year":"2016","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.011","article-title":"Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection","volume":"42","author":"Kearley","year":"2015","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1038\/s41467-019-09883-7","article-title":"IL-1beta, IL-23, and TGF-beta drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation","volume":"10","author":"Golebski","year":"2019","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00691","article-title":"ILC2 lung-homing in cystic fibrosis patients: functional involvement of CCR6 and impact on respiratory failure","volume":"11","author":"Schulz-Kuhnt","year":"2020","journal-title":"Front Immunol"},{"key":"B28","year":""},{"key":"B29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.immuni.2016.06.017","article-title":"Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation","volume":"45","author":"Martinez-Gonzalez","year":"2016","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191172","article-title":"Tissue-specific pathways extrude activated ILC2s to disseminate type 2 immunity","volume":"217","author":"Ricardo-Gonzalez","year":"2020","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam5809","article-title":"S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense","volume":"359","author":"Huang","year":"2018","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac9593","article-title":"Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs","volume":"350","author":"Gasteiger","year":"2015","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.18.431426","article-title":"Brain endothelial CXCL12 attracts protective natural killer cells during ischemic stroke","volume":"20","author":"Wang","year":"2023","journal-title":"J Neuroinflamm"},{"key":"B34","doi-asserted-by":"crossref","first-page":"877005","DOI":"10.3389\/fimmu.2022.877005","article-title":"Tissue resident and migratory group 2 innate lymphoid cells","volume":"13","author":"Matha","year":"2022","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"crossref","first-page":"679509","DOI":"10.3389\/fimmu.2021.679509","article-title":"Migration of lung resident group 2 innate lymphoid cells link allergic lung inflammation and liver immunity","volume":"12","author":"Matha","year":"2021","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/mi.2013.105","article-title":"Hypertrophy of infected Peyer\u2019s patches arises from global, interferon-receptor, and CD69-independent shutdown of lymphocyte egress","volume":"7","author":"Schulz","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1038\/ncomms5821","article-title":"Resident CD4+ T cells accumulate in lymphoid organs after prolonged antigen exposure","volume":"5","author":"Ugur","year":"2014","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2021.100035","article-title":"Monitoring cellular movement with photoconvertible fluorescent protein and single-cell RNA sequencing reveals cutaneous group 2 innate lymphoid cell subtypes, circulating ILC2 and skin-resident ILC2","volume":"1","author":"Nakatani-Kusakabe","year":"2021","journal-title":"JID Innov"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.12.011","article-title":"Lymphocyte circadian clocks control lymph node trafficking and adaptive immune responses","volume":"46","author":"Druzd","year":"2017","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2021.100015","article-title":"The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: a population-based study","volume":"1","author":"Groves","year":"2021","journal-title":"Lancet Reg Health Am"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1716115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:50:22Z","timestamp":1781106622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1716115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2026.1716115"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1716115","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1716115"}}